z-logo
open-access-imgOpen Access
The Uterine Adenosarcoma in a Young Woman Treated by TAH/BOS and Combined Adjuvant Therapy: A Case Report
Author(s) -
Soodabeh Shahidsales,
Marjaneh Farazestanian,
Noorieh SharifiSistani,
Sara Rasta,
Seyed Alireza Javadinia
Publication year - 2020
Publication title -
acta medica iranica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.218
H-Index - 27
eISSN - 1735-9694
pISSN - 0044-6025
DOI - 10.18502/acta.v58i3.3779
Subject(s) - medicine , hysterectomy , adjuvant chemotherapy , radiation therapy , adjuvant radiotherapy , adjuvant therapy , abdominal hysterectomy , stage (stratigraphy) , surgery , adjuvant , gynecology , metastasis , chemotherapy , cancer , oncology , breast cancer , paleontology , biology
We aimed to report a woman suffering from uterine adenosarcoma in the perimenopause period. The patient had undergone total abdominal hysterectomy (TAH) with bilateral salpingo-oophorectomy (BSO) and also received adjuvant chemotherapy and radiotherapy. Moreover, she was reported as disease-free with no evidence of recurrence or metastasis despite the existence of numerous risk factors such as deep myometrial invasion as well as sarcomatous overgrowth after one year of follow-up. The results obtained about this patient could highlight the role of adjuvant therapy in terms of managing treatments for patients suffering from MASO, especially in the presence of deep myometrial invasion and an advanced stage. © 2020 Tehran University of Medical Sciences. All rights reserved. Acta Med Iran 2020;58(3):138-141.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom